We are live on ! Find out more
DSC

Duncker Streett & Co Portfolio holdings

AUM $591M
1-Year Est. Return 26.48%
This Fund
S&P 500
This Quarter Est. Return
+3.51%
1 Year Est. Return
+26.48%
3 Year Est. Return
+90.92%
5 Year Est. Return
+109.52%
10 Year Est. Return
+349.63%
AUM
$520M
AUM Growth
+$13.6M
Cap. Flow
+$3.32M
Cap. Flow %
0.64%
Top 10 Hldgs %
29.13%
Holding
499
New
22
Increased
82
Reduced
112
Closed
12

Top Buys

Rank Stock Value
1
UBER icon
Uber
UBER
+$4.26M
2
FSLR icon
First Solar
FSLR
+$3.58M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.79M
4
AXON
Axon Enterprise
AXON
+$1.55M
5
CDNS icon
Cadence Design Systems
CDNS
+$1.12M

Top Sells

Rank Stock Value
1
CDW icon
CDW
CDW
+$3M
2
EOG icon
EOG Resources
EOG
+$2.05M
3
ELV icon
Elevance Health
ELV
+$1.59M
4
IGSB icon
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
+$1.02M
5
NVDA icon
NVIDIA
NVDA
+$613K

Sector Composition

Rank Sector Weight
1 Technology 25.68%
2 Healthcare 13.94%
3 Financials 12.53%
4 Industrials 11.26%
5 Consumer Discretionary 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IYY icon
401
iShares Dow Jones US ETF
IYY
$3.07B
$13.2K ﹤0.01%
100
– –
LNG icon
402
Cheniere Energy
LNG
$54.9B
$13.1K ﹤0.01%
75
– –
HYD icon
403
VanEck High Yield Muni ETF
HYD
$4.4B
$12.9K ﹤0.01%
250
– –
QUAL icon
404
iShares MSCI USA Quality Factor ETF
QUAL
$48.1B
$12.3K ﹤0.01%
72
– –
PAAS icon
405
Pan American Silver
PAAS
$21.9B
$12.2K ﹤0.01%
613
– –
VGLT icon
406
Vanguard Long-Term Treasury ETF
VGLT
$10.3B
$11.8K ﹤0.01%
205
– –
IBB icon
407
iShares Biotechnology ETF
IBB
$9.8B
$11.4K ﹤0.01%
83
-45
-35% -$6.01K
MRNA icon
408
Moderna
MRNA
$23.7B
$11.3K ﹤0.01%
95
– –
ALG icon
409
Alamo Group
ALG
$2.05B
$11.2K ﹤0.01%
65
-296
-82% -$57.7K
TFX icon
410
Teleflex
TFX
$5.87B
$10.5K ﹤0.01%
50
– –
AVT icon
411
Avnet
AVT
$8.09B
$10.3K ﹤0.01%
200
– –
GILD icon
412
Gilead Sciences
GILD
$165B
$10.3K ﹤0.01%
150
-400
-73% -$26.7K
AMT icon
413
American Tower
AMT
$78.9B
$10.1K ﹤0.01%
52
– –
WBD icon
414
Warner Bros
WBD
$67.5B
$9.94K ﹤0.01%
1,336
-143
-10% -$1.15K
DOC icon
415
Healthpeak Properties
DOC
$14.5B
$9.8K ﹤0.01%
500
– –
XLRE icon
416
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.54B
$9.6K ﹤0.01%
250
– –
OXY icon
417
Occidental Petroleum
OXY
$58.5B
$9.46K ﹤0.01%
150
– –
LNC icon
418
Lincoln National
LNC
$8.72B
$9.33K ﹤0.01%
300
– –
GWW icon
419
W.W. Grainger
GWW
$60.8B
$9.02K ﹤0.01%
10
– –
KD icon
420
Kyndryl
KD
$2.99B
$8.5K ﹤0.01%
323
– –
BRO icon
421
Brown & Brown
BRO
$23.8B
$8.31K ﹤0.01%
93
– –
VFC icon
422
VF Corp
VFC
$5.81B
$8.1K ﹤0.01%
600
– –
LECO icon
423
Lincoln Electric
LECO
$15.2B
$7.92K ﹤0.01%
42
– –
MGV icon
424
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.6B
$7.82K ﹤0.01%
66
– –
USHY icon
425
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.1B
$7.73K ﹤0.01%
+213
New +$7.7K
15 16
17
18 19

Similar funds

BBL
Beck Bode LLC Dedham, Massachusetts $591M AUM 37.12% 1-Year Est. Return
DPRC
Deer Park Road Corp Steamboat Springs, Colorado $591M AUM 27.7% 1-Year Est. Return
SM
Sunriver Management Greenwich, Connecticut $591M AUM 2.74% 1-Year Est. Return
LBIM
Land & Buildings Investment Management Stamford, Connecticut $591M AUM 10.19% 1-Year Est. Return
BA
Bellwether Advisors Lincoln, Nebraska $590M AUM 35.66% 1-Year Est. Return
FL
Fourthstone LLC St Louis, Missouri $590M AUM 29.58% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
EGWAG
Elwood & Goetz Wealth Advisory Group Athens, Georgia $589M AUM 19.26% 1-Year Est. Return

Duncker Streett & Co's Q2 2024 Portfolio in Review

As of Q2 2024, Duncker Streett & Co held 499 positions worth $520M, up 2.7% from $507M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Duncker Streett & Co's Q2 2024 filing shows 22 new, 82 increased, 112 reduced and 12 closed positions. Its largest new stake was Vertex Pharmaceuticals: 6,425 shares worth $3.01M. The largest sale was CDW, an estimated $3M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Duncker Streett & Co's largest Q2 2024 buy was Vertex Pharmaceuticals: 6,425 shares worth $3.01M.
  • Duncker Streett & Co added most to Uber in Q2 2024, an estimated $4.26M increase.
  • Duncker Streett & Co's biggest Q2 2024 reduction was CDW, cutting an estimated $3M.
  • Duncker Streett & Co fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $512K.
  • Duncker Streett & Co's ten largest holdings make up 29% of its $520M portfolio in Q2 2024.
  • Duncker Streett & Co opened 22 new positions and closed 12 in Q2 2024.
  • Duncker Streett & Co's portfolio value rose 2.7% quarter-over-quarter to $520M.

Based on Duncker Streett & Co's 13F filing for Q2 2024, filed 31 Jul 2024.